Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.1.1 Reimbursement process
4.1.2 Increasing Awareness and care testing
4.1.3 Clear and High growth and commonness
4.2 Restraints
4.2.1 Complex process in Diagnosis
4.3 Opportunities
4.3.1 Development in point care testing
4.4 Challenges
4.4.1 Limited budgets and Availability
4.4.2 Dearth of skilled professionals and diagnostics centres
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 Polymerase chain reaction
6.3 Isothermal Nucleic acid Amplification Technology
6.4 Hybridization
6.5 DNA sequencing and next-generation sequencing
6.6 Microarrays
6.7 Other Technologies
Chapter 7 Market Segmentation by Product
7.1 Introduction
7.2 Reagents and kits
7.3 Instruments
Chapter 8 Market Segmentation by Application
8.1 Introduction
8.2 Infectious diseases
8.3 Oncology
8.4 Blood screening
8.5 Microbiology
8.6 Genetic tests
8.7 Others
Chapter 8 Market Segmentation by Geography
8.1 North America
8.1.1 Introduction
8.1.2 USA
8.1.3 Canada
8.1.4 Others
8.2 Europe
8.2.1 Introduction
8.2.2 UK
8.2.3 France
8.2.4 Germany
8.2.5 Italy
8.2.6 Spain
8.2.7 Others
8.3 Asia
8.3.1 Introduction
8.3.2 Japan
8.3.3 China
8.3.4 India
8.3.5 Others
8.4 The Middle East & Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1 Myriad Genetics
10.1.1 Business Overview
10.1.2 Product portfolio
10.1.3 Key Strategy
10.1.4 Recent Developments
10.2 Agilent/Dako
10.3 Hologic
10.4 Illumina
10.5 Cepheid
10.6 Roche Diagnostics
10.7 BD(Beckton,Dickinson & Co)
10.8 Abbott Laboratories
10.9 Qiagen
10.11 Agendia
10.12 Grifols
10.13 bioMérieux
10.14 Foundation Medicine
10.15 Genomic Health
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
11.1.2 Market Estimates and Forecast by Application 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
11.1.4 Market Estimates and Forecast by Company 2018-2024 (USD Million)
11.1.5 Market Estimates and Forecast by Product 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
